Latest ResoTher Pharma News & Updates
See the latest news and media coverage for ResoTher Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical-stage biotech developing resolution therapies for cardiovascular inflammation
resotherpharma.com- Headquarters
- Holte, Denmark
- Founded year
- 2016
- Company type
- Private company
- Number of employees
- 2–20
Last updated
Latest news about ResoTher Pharma
In short: ResoTher Pharma initiated a Phase 2a clinical trial for its cardiovascular drug RTP-026 and secured significant grant funding for its development.
Company announcements
-
CFO chooses ResoTher Pharma
CFO of two companies selects ResoTher due to exciting funding, biotech passion, and Phase 2 trial launch. Article in Danish.
-
ResoTher Pharma initiates dosing in Phase 2a trial
The trial assesses RTP-026 safety and efficacy in STEMI patients at sites in Denmark and UK. It aims to enroll 96 patients.
-
ResoTher Pharma receives €2.5 million EIC grant
The grant supports Phase 2a clinical study of RTP-026 for myocardial infarction. One of 47 projects selected from 648 proposals.
-
ResoTher Pharma appoints Anders Kronborg as CEO
The appointment takes effect February 1, 2023. He succeeds Lone Veng, who led since 2017 and advanced RTP-026 into clinical development.
Media coverage
-
Resother Pharma synthesizes new FPR2 agonists
Resother Pharma ApS has divulged new N-formyl peptide receptor 2 (FPR2; FPRL1; LXA4) agonists potentially useful for the treatment of chronic inflammation.
-
ResoTher Pharma works with peptide-based molecules
ResoTher Pharma is a Danish biotech company that develops new therapeutic agents based on a unique approach to inflammatory treatment. ResoTher works with peptide-based molecules that...
Track ResoTher Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
ResoTher Pharma competitors & trending companies
Browse news for competitors to ResoTher Pharma and other trending companies.
Abarceo Pharma
Lipigon
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze